BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Search Results - 735 to 750 of 950

Ophidia Products, Inc.

Ophidia Products, Inc. is a privately held Texas corporation founded in 1991 for the purpose of discovering biologics for the treatment of human diseases and disorders. The founder and president, Dr....
www.ophidia.com/        View full profile

Optimer Pharmaceuticals

Optimer's core competence includes the development of innovative drugs for treating diseases that currently have no satisfactory therapy. These include antibiotics for drug-resistant bacterial...
www.optimerpharma.com/        View full profile

Optivus

Loma Linda University Medical Center, (LLUMC), a major southern California teaching medical center undertook the unprecedented challenge of building the world’s first hospital-based Proton Beam Cancer...
www.optivus.com/        View full profile

ORIDIS Biomed GmbH

ORIDIS™ Biomed is a biomedical company focusing on the discovery and development of therapeutics and targeted treatment solutions for liver cancer and metabolic diseases of the liver.ORIDIS™ Biomed...
www.oridis-biomed.com/        View full profile

Orion Genomics.

Orion Genomics develops oncology diagnostic products for cancer screening and therapy selection. We leverage our suite of proprietary technologies to find and interpret normal and abnormal epigenetic...
www.oriongenomics.com/        View full profile

Ortho Biotech

In 1990, Ortho Biotech was established as the first biotechnology subsidiary of Johnson & Johnson.Today, our products and treatments combat some of the most serious diseases - such as cancer, HIV/AIDS...
www.orthobiotech.ca/        View full profile

OsteoScreen

OsteoScreen Inc. is a privately held biotechnology company that focuses on the identification and clinical development of new drugs for common diseases of bone. OsteoScreen has been funded for 14...
www.osteoscreen.com/        View full profile

BioMedica Inc.

Oxford BioMedica (LSE: OXB) is a biopharmaceutical company specialising in the development of novel gene-based therapeutics with a focus on the areas of oncology and neurotherapy. The Company was...
www.oxfordbiomedica.co.uk/        View full profile

OXIS International

OXIS International, Inc. develops technologies and products to research, diagnose, treat and prevent diseases of oxidative stress associated with damage from free radical and reactive oxygen species...
www.oxis.com/        View full profile

Pacific Shores Medical Group

We are a specialized hematology and oncology practice providing state-of-the-art treatments for adult patients with any type of cancer or blood disorder. We have been in operation for 20 years, and we...
www.pacshoresoncology.com/        View full profile

The Hospital of the University of Pennsylvania

A leader in medicine for more than 240 years, Penn opened its School of Medicine, the nation's first, in 1765. The Hospital of the University of Pennsylvania was established in 1874 as the nation's...
www.pahosp.com/        View full profile

Panacea Pharmaceuticals, Inc.

Panacea Pharmaceuticals, Inc. was founded in 1999 to discover, develop, and commercialize novel therapeutic and diagnostic products for cancer and diseases of the central nervous system and cancer.The...
www.panaceapharma.com/        View full profile

Panagin Pharmaceuticals Inc.

Panagin Pharmaceuticals Inc., a privately-held biotech company, specializes in the discovery, research, development and commercialization of saponin based anti-cancer drugs. Panagin's proprietary new...
www.panagin.com/        View full profile

Paradigm Therapeutics Ltd

Paradigm Therapeutics was founded in 1999 and has established world class target identification and validation capabilities based on gene knock out technology and in vivo pharmacology. The acquisition...
www.paradigm-therapeutics.co.uk/        View full profile

Paradigm Therapeutics Ltd

Paradigm Therapeutics was founded in 1999 and has established world class target identification and validation capabilities based on gene knock out technology and in vivo pharmacology. The acquisition...
www.paradigm-therapeutics.com/        View full profile

 [First Page]   [Prev]   1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49  50  51   52   53   54   55   56   57   58   59   60   61   62   63   64   [Next]   [Last Page] 



This site uses Thumbshots previews, resources from the NCBI applied.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.